Clear Cell Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Clear Cell Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2014-09-25Clinical Trial Update: Investigating Patient Satisfaction With Oral Anti-Cancer Treatment
A completed clinical trial investigating patient satisfaction with an oral anti-cancer treatment sponsored by KU Leuven for Clear Cell Renal…
-
CLINICAL_TRIALS trial_result · 2014-09-11Clinical Trial Update: CCI-779 and Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney Cancer [Phase 1, Phase 2]
Phase 1/2 trial update of CCI-779 (temsirolimus) and bevacizumab in metastatic or unresectable kidney cancer has completed with posted resul…
-
CLINICAL_TRIALS trial_result · 2014-07-16Clinical Trial Update: Rotating Pazopanib and Everolimus to Avoid Resistance [Phase 2]
A Phase 2 study examining rotating pazopanib and everolimus to prevent therapy resistance in clear cell renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2014-06-24Clinical Trial Update: A Study Comparing AZD2014 vs Everolimus in Patients With Metastatic Renal Cancer [Phase 2]
A Phase 2 trial comparing AZD2014 and Everolimus in metastatic clear cell renal cell carcinoma has been terminated.
-
CLINICAL_TRIALS research · 2014-06-12Clinical Trial Update: A Phase II Study Investigating Upfront Pazopanib In Metastatic Renal Cancer Renal Cancer (Panther)
A Phase II clinical trial evaluating upfront pazopanib for metastatic clear cell renal cell carcinoma (Panther) is described, with current s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-12-02Clinical Trial Update: Effect of Sorafenib on ccRCC Uptake of Radiolabeled Bevacizumab or cG250 [NA]
The study completed and evaluated whether sorafenib affects the uptake of radiolabeled bevacizumab or girentuximab (cG250) in clear cell ren…
-
CLINICAL_TRIALS trial_result · 2013-11-20Clinical Trial Update: AZD2171 in Treating Patients With Refractory Metastatic Kidney Cancer [Phase 2]
Phase 2 trial of cediranib (AZD2171) in patients with refractory metastatic kidney cancer was terminated, with results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-11-13Clinical Trial Update: Dose Escalation Study Investigating Everolimus and Dovitinib in Metastatic Clear Cell Renal Cancer [Phase 1]
A Phase 1 dose-escalation trial evaluating the combination of everolimus and dovitinib in metastatic clear cell renal cell carcinoma has com…
-
CLINICAL_TRIALS trial_result · 2013-07-02Clinical Trial Update: Sorafenib and Interferon Alfa in Treating Patients With Locally Advanced or Metastatic Kidney Cancer [Phase 2]
Phase 2 clinical trial evaluating sorafenib in combination with interferon alfa-2b for locally advanced or metastatic renal cell carcinoma; …
-
CLINICAL_TRIALS trial_result · 2013-06-28Clinical Trial Update: Sorafenib Tosylate and Bevacizumab in Treating Patients With Advanced Kidney Cancer [Phase 1, Phase 2]
A Phase 1/Phase 2 trial evaluating the combination of sorafenib tosylate and bevacizumab in advanced renal cell carcinoma, with results post…
-
CLINICAL_TRIALS trial_result · 2013-05-14Clinical Trial Update: Study of MDX-1411 Given Every 14 Days With Pre-medications to Subjects With Clear Cell Kidney Cancer. [Phase 1]
Phase 1 study of MDX-1411 given every 14 days with pre-medications in clear cell renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-03-06Clinical Trial Update: Bevacizumab (Avastin) and RAD001(Everolimus)in the Treatment of Advanced Clear Cell Renal Carcinoma [Phase 2]
This update summarizes results from a Phase 2 trial evaluating the combination of bevacizumab (Avastin) and everolimus (RAD001) for advanced…
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: Sorafenib and Interferon Alfa in Treating Patients With Metastatic or Unresectable Kidney Cancer [Phase 2]
This Phase 2 clinical trial evaluated the combination of sorafenib and interferon alfa in patients with metastatic or unresectable renal cel…
-
CLINICAL_TRIALS trial_result · 2013-01-14Clinical Trial Update: Bevacizumab, Erlotinib, and Imatinib in the Treatment of Advanced Renal Cell Carcinoma [Phase 1, Phase 2]
Phase 1/2 study of bevacizumab, erlotinib, and imatinib in advanced clear cell renal cell carcinoma has completed, with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2012-12-31Clinical Trial Update: Sorafenib in Treating Patients Who Are Undergoing Surgery for Metastatic Kidney Cancer [Phase 2]
Phase 2 trial evaluating sorafenib in patients undergoing surgery for metastatic kidney cancer was terminated; results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-03-12Clinical Trial Update: Vandetanib to Treat Advanced Kidney Cancer [Phase 2]
Phase 2 study of Vandetanib for advanced Clear cell renal cell carcinoma was terminated; results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2011-06-23Clinical Trial Update: Neoadjuvant Sunitinib Treatment for Metastatic Clear Cell Renal Cell Carcinoma (RCC) [Phase 2]
This document describes a Phase 2 trial evaluating neoadjuvant sunitinib for metastatic clear cell renal cell carcinoma; the current status …
-
CLINICAL_TRIALS trial_result · 2011-01-25Clinical Trial Update: GW786034 In Subjects With Locally Recurrent Or Metastatic Clear Cell Renal Cell Carcinoma [Phase 2]
Phase 2 trial of GW786034 in locally recurrent or metastatic clear cell renal cell carcinoma has completed, with results posted.